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Abstract
AIM: To determine whether 2-(3-carboxy-1-oxopropy1)
amino-2-deoxy-D-glucose (COPADG), a derivative of D-
amino-glucose, inhibited the growth of human esophageal
cancer cell line Eca-109.
METHODS: Effects of COPADG on Eca-109 cells cultured
in RPMI 1640 medium were examined by a tetrazolium-
based colorimetric assay (MTT assay).
RESULTS: COPADG inhibited the growth of Eca-109 cells
in a dose- and time-dependent manner; the maximum
inhibition rate was 83.75%.
CONCLUSION: COPADG can directly inhibit the proliferation
of Eca-109 cells, which may serve as the experimental
evidence for development of new drugs for esophageal
cancer therapy.
Wu J, Lu H, Zhou Y, Qiao L, Ji R, Wang AQ, Liu WM, Xue QJ.
Effect of 2-(3-carboxy-1-oxopropyl) amino-2-deoxy-D-glucose
on human esophageal cancer cell line. World J Gastroenterol
2004; 10(22): 3380-3381
http://www.wjgnet.com/1007-9327/10/3380.asp
INTRODUCTION
2-(3-carboxy-1-oxopropy1) amino-2-deoxy-D-glucose (COPADG,
structure is shown in Figure 1) is a derivative of D-glucose, a
monose derivative of degraded chitosan. Previous researches have
discovered that some amino-D-glucose derivatives are capable of
inducing leukemia K562 cells to differentiate into macrophages[1],
but their efficacy in inducing apoptosis of tumor cells remains
unclear. We conducted this study to determine whether
COPADG could inhibit the proliferation of human esophageal
cancer cell line Eca-109, to provide experimental evidence for
new drug development for esophageal cancer therapy.
MATERIALS AND METHODS
Materials
COPADG, synthesized by the Lanzhou Institute of Chemical
Physics of Chinese Academy of Sciences, was dissolved in
distilled water, filter-sterilized with 0.22 µm filter disc, and stored
at 4  until use. Eca-109 cells were purchased from Shanghai
Institute of Cell Biology of Chinese Academy of Sciences. RPMI
1640 medium, agarose, trypsin and fetal bovine serum (FBS)
were obtained from Gibco BRL Company, and the reagents for
MTT assay were purchased from Sigma Chemical Co. Ltd.
Cell culture
Eca-109 cells growing in logarithmic phase were cultured in RPMI
1640 medium supplemented with 100 mL/L heat-inactivated FBS,
100 µg/mL penicillin and 100 µg/mL streptomycin. The cells
were maintained in a humidified atmosphere containing 50 mL/L
CO2 at 37 . The medium was replaced every 48 h.
MTT colorimetric assay
MTT assay[2] was based on the enzymatic reduction of the
tetrazolium salt MTT in viable and metabolically active cells.
Cells at 85% to 100% confluency were harvested with the
mixture of 2.5 g/L trypsin and 0.2 g/L EDTA solution and seeded
into a 96-well plate at a density of 4×103 /well, followed by
incubation of the cells with COPADG at varied concentrations
(0.01-0.09 mol/L) for different lengths of time (24-96 h, Table 1).
The control cells were treated in the same way except that
incubation was performed with sterile PBS instead of COPADG.
After treatment, the medium was replaced by fresh medium and
the cells were incubated for 4 h with 5 mg/mL MTT, which was
dissolved in 150 µL of 100 g/L DMSO and kept for 1 h. The
optical densities at 490 nm (A490nm) in the 96-well plates were
determined using a microplate reader. Cell growth inhibition
was estimated with the following formula: Growth inhibition
(%) =1-A490nm (treated cells)/A490nm (control cells) ×100%.
Statistical analysis
Results were expressed as mean±SD. Each experiment was
repeated at least three times. Statistical differences between
each group were determined by single-factor analysis of
variance and correlation analysis using SPSS 11.0 statistical
software.
Figure 1  Chemical structure of 2-(3-carboxy-1-oxoprogy1)
amino-2-deoxy-D-glucose.
RESULTS
COPADG could effectively inhibit the growth of Eca-109 cells,
the maximum inhibition rate was 83.75%. The inhibition exhibited
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an obvious time-and dose-dependent manner when the
COPADG concentrations were below 0.05 mol/L, and higher
concentrations tended to induce gradually stabilized inhibition,
suggesting a saturation of the effects of COPADG (Table 1,
Figure 2).
Figure 2  Inhibition of Eca-109 cell growth by COPADG.
DISCUSSION
COPADG is a derivative of D-glucose, which is a low-molecular-
weight compound with multiple biological activities and a
monosaccharide derived from chitosan through release of an
acetyl group followed by degradation of the residual group.
D-glucose is the intermediate during the synthesis of protein-
polysaccharide macromolecules, and distributed in almost every
human tissue as a part of the structural components of cell
membrane and tissues. From the biological standpoint, D-glucose
not only is involved in hepatic and renal detoxification against
toxic agents, but also acts to stimulate the anti-inflammatory
response and enhance the synthesis of protein-polysaccharides.
Studies[3,4] have also shown that D-glucose could inhibit tumor
cell growth, and partial derivatives of D-glucose could potently
induce differentiation of tumor cells. Some D-amine-glucose
derivatives were able to induce leukemia K562 cells to
differentiate into macrophages[5], but this effect failed to be
observed in human hepatocellular carcinoma cell line[1].
Currently, COPADG has become a new focus of interest in
cancer therapy.
     By conducting this study, we aimed to test whether COPADG,
the newest derivative of D-glucose, had any effect on the
proliferation of human esophageal cancer cells. MTT assay
showed that COPADG could effectively inhibit Eca-109 cell
Table 1  Inhibitory effect of COPADG on the proliferation of esophageal cancer cell line Eca-109 (mean±SD)
Concentra-tion                                 A490nm                   Inhibitory rate (%)
      (mol/L)
      24 h       48 h        72 h    24 h    48 h    72 h
0 (Control) 1.505±0.090 1.686±0.067 1.745±0.077   12.76    20.81    31.29
0.01 1.313±0.053b 1.336±0.057b 1.199±0.083b   12.76    20.81    31.29
0.03 0.958±0.028 0.966±0.086 0.900±0.056   36.35    42.68    48.42
0.05 0.400±0.064b,c 0.429±0.065b,a 0.384±0.050b,c   73.42    74.57    77.99
0.07 0.383±0.045 0.360±0.039 0.342±0.037   74.55    78.66    80.44
0.09 0.355±0.046c 0.362±0.053 c 0.280±0.039a   76.41    78.54    83.75
At the same time point, P<0.01 vs the control group; bP<0.01 vs 0.03 mol/L; aP<0.05, cP>0.05 vs 0.07 mol/L.
proliferation, in a marked time- and dose-dependent manner
below the concentration of 0.05 mol/L; the maximum inhibition
rate was 83.75%. The inhibition, however, became stable when
the concentrations were higher than 0.05 mol/L, indicating that
the effects of the drug might be saturated at this concentration.
      The development of cancer has been considered to be the
combined results of unrestricted cell proliferation and impairment
of normal cell apoptosis[6]. These concepts provide a basis
for the development of new strategies for cancer treatment.
Agents with antiproliferative properties and proapoptotic effects
have been widely investigated as potential chemotherapeutic
options[7,8].
        Conclusion, COPADG has obvious time- and concentration-
dependent inhibitory effects against the proliferation of human
esophageal cancer cell line Eca-109
 
in vitro, but whether this
effect can be achieved in other cell lines still awaits further
examination, which may also be necessary to clarify the
mechanism underlying this effect.
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